KR960703593A - (R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine) - Google Patents
(R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine) Download PDFInfo
- Publication number
- KR960703593A KR960703593A KR1019960700919A KR19960700919A KR960703593A KR 960703593 A KR960703593 A KR 960703593A KR 1019960700919 A KR1019960700919 A KR 1019960700919A KR 19960700919 A KR19960700919 A KR 19960700919A KR 960703593 A KR960703593 A KR 960703593A
- Authority
- KR
- South Korea
- Prior art keywords
- amlodipine
- pharmaceutically acceptable
- isomer
- acceptable salt
- smooth muscle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
암로피딘의 R(+) 이성질체는 그의 칼슘 채널 차단 활성의 결여에도 불구하고, 평활근 세포 이동의 강력한 억제제이다. 이 약제는 아테롬성 동맥경화증, 후 벌룬 혈관형성술에 수반하는 재협착증의 체료에 유용하다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (7)
- 혈관 평활근 세포 이동의 억제를 필요로 하는 질환의 치료에 사용하기 위한 암로디핀의 R(+) 이성질체 또는 제약학적으로 허용가능한 그의 염.
- 평활근 세포 이동의 억제를 필요로 하는 질환 치료용 약제를 제조하기 위한 암로디핀의 R(+) 이성질체 또는 제약학적으로 허용가능한 그의 염의 용도.
- 평활근 세포 이동의 억제를 필요로 하는 질환의 환자에게 유효량의 암로디핀의 R(+) 이성질체 또는 제약학적으로 허용가능한 그의 염을 투여하는 것으로 이루어지는 평활근 세포 이동의 억제를 필요로 하는 질환의 치료 방법.
- 암로디핀의 R(+) 이성질체 또는 제약학적으로 허용가능한 그의 염 및 제약학적으로 허용가능한 담체 또는 회석제로 이루어진 칼슘 채널 차단 활성이 실질적으로 없는 제약 조성물.
- 제4항에 있어서, 암로디핀의 R(+) 이성질체 또는 제약학적으로 허용 가능한 그의 염을 1 내지 100mg 함유하는 경구 투여용 단위 투여형의 조성물.
- 제5항에 있어서, 암로디핀의 R(+) 이성질체 또는 제약학적으로 허용 가능한 그의 염을 20mg 함유하는 단위 투여형의 제약 조성물.
- 제4항에 있어서, 암로디핀의 R(+) 이성질체 또는 제약학적으로 허용 가능한 그의 염을 1 내지 20mg 함유하는 정맥내 투여용 단위 투여형의 제약 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9317773.1 | 1993-08-26 | ||
GB939317773A GB9317773D0 (en) | 1993-08-26 | 1993-08-26 | Therapeutic compound |
PCT/EP1994/002697 WO1995005822A1 (en) | 1993-08-26 | 1994-08-10 | Inhibition of smooth muscle cell migration by (r)-amlodipine |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960703593A true KR960703593A (ko) | 1996-08-31 |
KR0163840B1 KR0163840B1 (ko) | 1998-12-01 |
Family
ID=10741080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960700919A KR0163840B1 (ko) | 1993-08-26 | 1994-08-10 | (r)-암로디핀에 의한 평활근 세포 이동의 억제 |
Country Status (20)
Country | Link |
---|---|
US (1) | US6080761A (ko) |
EP (1) | EP0754043B1 (ko) |
JP (2) | JP3007992B2 (ko) |
KR (1) | KR0163840B1 (ko) |
CN (1) | CN1060039C (ko) |
AT (1) | ATE192337T1 (ko) |
AU (1) | AU686658B2 (ko) |
CA (1) | CA2170278C (ko) |
DE (1) | DE69424317T2 (ko) |
DK (1) | DK0754043T3 (ko) |
ES (1) | ES2145149T3 (ko) |
GB (1) | GB9317773D0 (ko) |
GR (1) | GR3033547T3 (ko) |
IL (1) | IL110700A (ko) |
NO (1) | NO308826B1 (ko) |
NZ (1) | NZ271993A (ko) |
PT (1) | PT754043E (ko) |
TW (1) | TW470646B (ko) |
WO (1) | WO1995005822A1 (ko) |
ZA (1) | ZA946475B (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7129265B2 (en) * | 1999-04-23 | 2006-10-31 | Mason R Preston | Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy |
GB0020842D0 (en) * | 2000-08-23 | 2000-10-11 | Pfizer Ltd | Therapeutic compositions |
US6737430B2 (en) | 2000-11-09 | 2004-05-18 | Pfizer, Inc. | Mutual prodrug of amlodipine and atorvastatin |
AT5874U1 (de) * | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
AU2001294354A1 (en) * | 2000-12-29 | 2002-07-16 | Bioorganics B.V. | Process for making amlodipine, derivatives thereof, and precursors therefor |
CN1152013C (zh) * | 2001-11-22 | 2004-06-02 | 张喜田 | 一类左旋氨氯地平盐的水合物及其制剂 |
EP1802576B1 (en) * | 2004-10-20 | 2008-06-25 | Emcure Pharmaceuticals Limited | Process for producing enantiomer of amlodipine in high optical purity |
KR100828883B1 (ko) * | 2006-10-27 | 2008-05-09 | 씨제이제일제당 (주) | 라세믹 암로디핀으로부터 s-(-)-암로디핀의 분리방법 |
KR100830003B1 (ko) * | 2006-10-31 | 2008-05-15 | 씨제이제일제당 (주) | 결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8804630D0 (en) * | 1988-02-27 | 1988-03-30 | Pfizer Ltd | Preparation of r-& s-amlodipine |
GB9405833D0 (en) * | 1994-03-24 | 1994-05-11 | Pfizer Ltd | Separation of the enantiomers of amlodipine |
-
1993
- 1993-08-26 GB GB939317773A patent/GB9317773D0/en active Pending
-
1994
- 1994-08-10 WO PCT/EP1994/002697 patent/WO1995005822A1/en active IP Right Grant
- 1994-08-10 EP EP94926189A patent/EP0754043B1/en not_active Expired - Lifetime
- 1994-08-10 JP JP7507319A patent/JP3007992B2/ja not_active Expired - Lifetime
- 1994-08-10 NZ NZ271993A patent/NZ271993A/en unknown
- 1994-08-10 KR KR1019960700919A patent/KR0163840B1/ko not_active IP Right Cessation
- 1994-08-10 AU AU76129/94A patent/AU686658B2/en not_active Ceased
- 1994-08-10 DE DE69424317T patent/DE69424317T2/de not_active Expired - Fee Related
- 1994-08-10 CN CN94193173A patent/CN1060039C/zh not_active Expired - Fee Related
- 1994-08-10 DK DK94926189T patent/DK0754043T3/da active
- 1994-08-10 US US08/596,365 patent/US6080761A/en not_active Expired - Fee Related
- 1994-08-10 PT PT94926189T patent/PT754043E/pt unknown
- 1994-08-10 ES ES94926189T patent/ES2145149T3/es not_active Expired - Lifetime
- 1994-08-10 AT AT94926189T patent/ATE192337T1/de not_active IP Right Cessation
- 1994-08-10 CA CA002170278A patent/CA2170278C/en not_active Expired - Fee Related
- 1994-08-18 IL IL11070094A patent/IL110700A/xx not_active IP Right Cessation
- 1994-08-19 TW TW083107624A patent/TW470646B/zh not_active IP Right Cessation
- 1994-08-25 ZA ZA946475A patent/ZA946475B/xx unknown
-
1996
- 1996-02-23 NO NO960730A patent/NO308826B1/no unknown
-
1999
- 1999-07-23 JP JP11208778A patent/JP2000044475A/ja active Pending
-
2000
- 2000-05-31 GR GR20000401239T patent/GR3033547T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69424317T2 (de) | 2000-08-24 |
EP0754043B1 (en) | 2000-05-03 |
PT754043E (pt) | 2000-09-29 |
CN1129907A (zh) | 1996-08-28 |
DE69424317D1 (de) | 2000-06-08 |
IL110700A (en) | 1999-04-11 |
NO960730D0 (no) | 1996-02-23 |
CN1060039C (zh) | 2001-01-03 |
GR3033547T3 (en) | 2000-09-29 |
CA2170278C (en) | 1999-08-03 |
EP0754043A1 (en) | 1997-01-22 |
US6080761A (en) | 2000-06-27 |
JPH08509004A (ja) | 1996-09-24 |
NZ271993A (en) | 1997-11-24 |
TW470646B (en) | 2002-01-01 |
NO960730L (no) | 1996-02-23 |
JP3007992B2 (ja) | 2000-02-14 |
WO1995005822A1 (en) | 1995-03-02 |
ZA946475B (en) | 1996-02-26 |
AU686658B2 (en) | 1998-02-12 |
NO308826B1 (no) | 2000-11-06 |
KR0163840B1 (ko) | 1998-12-01 |
JP2000044475A (ja) | 2000-02-15 |
ES2145149T3 (es) | 2000-07-01 |
CA2170278A1 (en) | 1995-03-02 |
IL110700A0 (en) | 1994-11-11 |
GB9317773D0 (en) | 1993-10-13 |
DK0754043T3 (da) | 2000-08-07 |
AU7612994A (en) | 1995-03-21 |
ATE192337T1 (de) | 2000-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053104D0 (no) | Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag. | |
RU2004106569A (ru) | Способ применения антибиотиков | |
RU95102778A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования потерь костной ткани и снижения уровня холестерина в сыворотке, фармацевтический препарат, содержащий 2-фенил-3-ароилбензотиофен | |
ES2164040T1 (es) | Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos. | |
AR035533A1 (es) | Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la | |
UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
KR960700061A (ko) | 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence) | |
RU94044436A (ru) | Способы подавления атрофии кожи и влагалища | |
NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
DE69227259T2 (de) | Film zur lokalen arzneistoffabgabe für periodontale behandlung | |
KR960703593A (ko) | (R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine) | |
RU94044454A (ru) | Ингибитор аутоимунных заболеваний | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
RU94044356A (ru) | Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с | |
DE69824313D1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
ATE235901T1 (de) | Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen | |
KR970061249A (ko) | 골다공증을 치료 또는 방지하기 위한 조성물 | |
RO117150B1 (ro) | Metodă pentru tratamentul afecţiunilor provocate de abuzul faţă de drog sau altă substanţă | |
DK0866711T3 (da) | Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö | |
KR940013503A (ko) | 동맥경화증의 예방 또는 치료용 약제학적 조성물 | |
FR2700166B1 (fr) | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. | |
NO955313D0 (no) | Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering | |
KR930702985A (ko) | 식도암의 치료 | |
BR0011884A (pt) | Método de tratamento da obesidade e condições comórbidas em um ser humano necessitando de tal tratamento, composto da fórmula i, produto contendo o composto da fórmula i, uso do composto da fórmula i, e, composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20030915 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |